At RHEM Labs, we are excited to announce that our innovative project, LoganAI, has advanced to Stage 2 of the National AI Sprint.This prestigious program recognises LoganAI's potential to significantly improve mental health diagnostics by leveraging artificial intelligence to transform traditional assessment methods.

LoganAI is designed to change the way mental health is assessed and managed, focusing on early detection and accurate diagnosis of conditions such as anxiety, depression, addiction, and autism. By integrating AI with existing diagnostic tools like Pfizer's GAD7 and PHQ-9, LoganAI converts static, paper-based forms into dynamic, real-time assessment tools that are embedded in daily life. Our proprietary prompting methodology utilizes state-of-the-art generative models to deliver diagnoses that are more precise and timely than conventional methods, thereby freeing up resources and enabling healthcare providers to focus on patient care.

Our progress in the AI Sprint allows us to further develop LoganAI with an extensive range of support and resources from Australia’s National AI Centre, Stone & Chalk, and Google Cloud. This support includes access to cutting-edge AI technologies, expert guidance, and financial backing, and is crucial as we aim to refine LoganAI’s functionality and expand its impact. Currently, we are in preliminary discussions with the Office for Autism in South Australia to integrate LoganAI into schools. This collaboration aims to improve the accessibility of diagnostic services within educational settings, offering neuro-affirming strategies that enhance learning experiences.

The potential of LoganAI extends beyond initial diagnostics. Over the next 12 months, we plan to expand our features to align with all five focus areas of South Australia's Autism Strategy. This will transform LoganAI from a screening tool into an ongoing support companion, making a significant difference in the lives of those within the mental health system.

​Over the next 6 weeks we will continue in our journey in the National AI Sprint and we are more committed than ever to developing LoganAI into a tool that not only supports but fundamentally changes mental health care.

We look forward to showcasing our advancements at the upcoming Demo Day and demonstrating how LoganAI can lead to more personalised and preventive care plans that substantially improve patient outcomes.

This is a pivotal moment for RHEM Labs, and we are eager to continue leading innovation in mental health diagnostics.